CONVERTIBLE DEBENTURE CONVERSION AGREEMENTConvertible Debenture Conversion Agreement • August 11th, 2023 • PetVivo Holdings, Inc. • Surgical & medical instruments & apparatus • Nevada
THIS CONVERTIBLE DEBENTURE CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of the 11th day of August, 2023 (“Effective Date”) by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”), and the individual listed on the signature page hereto (the “Debenture Holder”).
Henry EsberConvertible Debenture Conversion Agreement • March 28th, 2014 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations
Re: Amended and Restated 8% Convertible Debenture Conversion Letter AgreementConvertible Debenture Conversion Agreement • March 28th, 2014 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations
We are offering holders of the Innovus Pharmaceuticals, Inc. (“Innovus” or the “Company”) Amended and Restated 8% Convertible Debenture, dated November 11, 2013 (the “Debenture”), with the opportunity to do a one-time conversion of the outstanding principal and interest under the Debenture at a conversion rate of $0.40 per share of common stock of the Company.
